COMMUNIQUÉS West-GlobeNewswire
-
Ambio Life Sciences Partners with Athletes for Care to Provide Medically Supervised Ibogaine Programming and Support to Professional Athletes Living with Traumatic Brain Injury
15/10/2026 -
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
15/10/2026 -
Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X
15/10/2026 -
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
15/10/2026 -
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
15/10/2026 -
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
15/10/2026 -
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
15/10/2026 -
Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027
15/10/2026 -
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
15/10/2026 -
Precision Neuroscience™ Appoints Nevro Founder Konstantinos Alataris as President and Katherine Neuenfeldt as Senior Vice President, Commercial Strategies
15/10/2026 -
Clever Care Health Plan Introduces Expanded 2027 Medicare Advantage Benefits Package to Enhance Strong Member Experience
15/10/2026 -
UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
15/10/2026 -
Novonesis Opens Doors to Students to Inspire the Next Generation of U.S. Biomanufacturing Talent
15/10/2026 -
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
15/10/2026 -
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
15/10/2026 -
Sienna Announces October Dividend
15/10/2026 -
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
15/10/2026 -
CytoDyn to Host Investor Webcast
15/10/2026 -
TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls
15/10/2026
Pages
Other news
The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings
WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.
BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.
New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --
Company to host conference call on November 5, 2026, at 4:30 p.m. ET
PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.
Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation
TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.